Company / Tangible Book Value per Share
Zenas BioPharma, Inc. Tangible Book Value per Share History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Tangible Book Value per Share
$5.79
FY2025
5-year range
-$147.42 / $5.79
FY2023-FY2025
Trend
+104.0%
vs FY2024
Sector context
#92 of 209
Health Care
What the data says
At $5.79, Zenas BioPharma, Inc.'s tangible book value per share ranks #92 of 209 in the Health Care sector. Improved from $-147.42 to $5.79 over the past 2 years.
Based on SEC 10-K filings.
5.79 in FY2025.
Improved from $-147.42 to $5.79 over the past 2 years.
Health Care sector context is included.
Tangible Book Value per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#92 of 209 in Health CareTop 44% of 209This company $5.79 Sector average $93.47
▼
-93.8% below sector average
Key checks
Key Insights
- In FY2025, tangible book value per share increased 104.0% year-over-year.
- Ranks #92 out of 209 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -3.51 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Tangible Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $5.79 | +104.0% |
| FY2024 | -$143.15 | +2.9% |
| FY2023 | -$147.42 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026